Prognostic significance of tumoral Siglec-15 expression in solid tumors: a systematic review and meta-analysis. | ClinicLens

Siglec-15 has emerged as a novel immune checkpoint molecule and a potential therapeutic target in solid tumors. Previous studies reported inconsistent prognostic significance of tumoral Siglec-15 expression across cancer types. We therefore conducted a systematic review and meta-

Medical Literature · Updated 2026-08-05

← Back to articles

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.